Bradykinin receptor
From Wikipedia, the free encyclopedia
Identifiers | |
Symbol | BDKRB1 |
Entrez | 623 |
HUGO | 1029 |
OMIM | 600337 |
RefSeq | NM_000710 |
UniProt | P46663 |
Other data | |
Locus | Chr. 14 q32.1-32.2 |
Identifiers | |
Symbol | BDKRB2 |
Entrez | 624 |
HUGO | 1030 |
OMIM | 113503 |
RefSeq | NM_000623 |
UniProt | P30411 |
Other data | |
Locus | Chr. 14 q32.1-32.2 |
The bradykinin receptor is a receptor for bradykinin.
There are two Bradykinin receptors: the B1 receptor and the B2 receptor.[1]
[edit] B2 receptor
The B2 receptor is a G protein-coupled receptor, coupled to Gq and Gi. Gq stimulates phospholipase C to increase intracellular free calcium and Gi inhibits adenylate cyclase. Furthermore, the receptor stimulates the mitogen-activated protein kinase pathways. It is ubiquitously and constitutively expressed in healthy tissues.
The B2 receptor forms a complex with angiotensin converting enzyme (ACE), and this is thought to play a role in cross-talk between the renin-angiotensin system (RAS) and the kinin-kallikrein system (KKS). The heptapeptide angiotensin 1-7 (A1-7) also potentiates bradykinin action on B2 receptors.[2]
Ictibant is a second generation B2 receptor antagonist which has undergone limited clinical trials in pain and inflammation.
Kallidin also signals through the B2 receptor.
[edit] References
- ^ Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL (2005). "International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences". Pharmacol. Rev. 57 (1): 27–77. doi: . PMID 15734727.
- ^ Fernandes L, Fortes ZB, Nigro D, Tostes RC, Santos RA, Catelli De Carvalho MH (2001). "Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo". Hypertension 37 (2 Part 2): 703–9. PMID 11230360.
[edit] External links
|